Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P8
Near historical low
vs 3Y Ago
-3.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -292.25% |
| Q3 2025 | -68.42% |
| Q2 2025 | 4.25% |
| Q1 2025 | 194.46% |
| Q4 2024 | -14.41% |
| Q3 2024 | -43.32% |
| Q2 2024 | 41.58% |
| Q1 2024 | -1187.05% |
| Q4 2023 | 110.54% |
| Q3 2023 | -44.91% |
| Q2 2023 | 64.86% |
| Q1 2023 | -303.10% |
| Q4 2022 | 87.40% |
| Q3 2022 | -247.92% |
| Q2 2022 | 158.25% |
| Q1 2022 | 10.48% |
| Q4 2021 | -19.04% |
| Q3 2021 | 30.82% |
| Q2 2021 | -22.18% |
| Q1 2021 | 23.97% |
| Q4 2020 | -47.01% |
| Q3 2020 | 66.58% |
| Q2 2020 | -193.99% |
| Q1 2020 | 37.69% |
| Q4 2019 | -69.74% |
| Q3 2019 | 6.08% |
| Q2 2019 | 21.65% |
| Q1 2019 | 15.72% |
| Q4 2018 | -223.73% |
| Q3 2018 | 21.93% |
| Q2 2018 | -45.57% |
| Q1 2018 | -315.52% |
| Q4 2017 | 147.02% |
| Q3 2017 | -9.22% |
| Q2 2017 | 50.78% |
| Q1 2017 | -18.21% |
| Q4 2016 | -5.15% |
| Q3 2016 | 0.02% |
| Q2 2016 | -38.94% |
| Q1 2016 | -29.91% |